Arab Palestinian Investment Company (PEX:APIC)

Verve Therapeutics Ratios and Metrics

Market cap in millions JOD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	209	229	266	302	246	189
Market Cap Growth	-12.87%	-13.95%	-12.05%	23.07%	30.25%	17.24%
Enterprise Value	514	536	536	551	435	349
Last Close Price	1.30	1.77	2.06	2.28	1.80	1.37
PE Ratio	33.75	40.18	21.13	15.38	10.33	13.40
PS Ratio	0.25	0.29	0.32	0.37	0.31	0.28
PB Ratio	1.14	1.40	1.76	1.96	1.81	1.52
P/TBV Ratio	1.74	2.31	2.67	3.02	2.69	2.22
P/OCF Ratio	13.55	9.32	41.58	-	80.29	23.20
EV/Sales Ratio	0.62	0.67	0.64	0.67	0.55	0.51
EV/EBITDA Ratio	11.24	12.91	11.93	11.89	9.46	9.33
EV/EBIT Ratio	16.35	16.81	14.84	14.59	11.35	11.80
EV/FCF Ratio	-32.81	-	-	-	-	-
Debt / Equity Ratio	1.83	1.94	1.95	1.67	1.50	1.22
Debt / EBITDA Ratio	7.29	6.98	6.05	5.17	4.22	4.03
Asset Turnover	1.36	1.37	1.54	1.71	1.96	2.04
Inventory Turnover	7.00	6.48	6.90	8.25	10.18	10.31
Quick Ratio	0.72	0.67	0.73	0.73	0.95	0.82
Current Ratio	1.16	1.11	1.26	1.27	1.42	1.38
Return on Equity (ROE)	2.73%	3.79%	8.19%	14.95%	18.36%	14.83%
Return on Assets (ROA)	3.27%	3.42%	4.13%	4.88%	5.97%	5.53%
Return on Capital (ROIC)	4.04%	4.30%	5.26%	6.28%	7.80%	7.18%
Return on Capital Employed (ROCE)	10.60%	11.40%	12.30%	13.30%	15.30%	14.10%
Earnings Yield	2.09%	2.49%	4.73%	6.50%	9.69%	7.46%
FCF Yield	-7.51%	-3.99%	-5.98%	-13.71%	-0.38%	-0.55%
Dividend Yield	-	-	-	2.56%	3.36%	2.90%
Payout Ratio	-	-	60.06%	39.74%	21.50%	30.22%
Buyback Yield / Dilution	-0.05%	-	0.00%	-	-1.26%	-1.29%
Total Shareholder Return	-	-	0.00%	2.56%	2.10%	1.61%

Updated Feb 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.